| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.09▼ | 4.96▲ | 4.94▲ | 4.73▲ | 4.42▲ |
| MA10 | 5.05▲ | 4.88▲ | 4.85▲ | 4.48▲ | 4.04▲ |
| MA20 | 5.01▲ | 4.82▲ | 4.78▲ | 4.31▲ | 4.41▲ |
| MA50 | 4.89▲ | 4.66▲ | 4.51▲ | 3.97▲ | 3.83▲ |
| MA100 | 4.83▲ | 4.46▲ | 4.33▲ | 4.34▲ | 3.84▲ |
| MA200 | 4.77▲ | 4.37▲ | 3.91▲ | 3.98▲ | 4.28▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.022▲ | 0.018▲ | 0.083▲ | 0.025▲ |
| RSI | 72.659▲ | 72.745▲ | 77.790▲ | 68.571▲ | 56.635▲ |
| STOCH | 96.296▲ | 71.032 | 77.033 | 89.427▲ | 61.850 |
| WILL %R | -6.452▲ | -2.632▲ | -2.532▲ | -0.858▲ | -8.022▲ |
| CCI | 81.153 | 176.782▲ | 219.659▲ | 183.299▲ | 124.283▲ |
|
Tuesday, May 05, 2026 05:37 AM
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...
|
|
Tuesday, April 28, 2026 08:21 AM
ACHV Achieve Life Sciences, Inc. (NASDAQ: ACHV) generated significant news flow in April, announcing the arrival of a new CEO, substantial new financing, and a cytisinicline manufacturing update. On ...
|
|
Wednesday, April 15, 2026 12:00 AM
Detailed price information for Achieve Life Sciences Inc (ACHV-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 4.77 | 5.095 | 4.74 | 5.085 | 600,539 |
| 07/05/26 | 4.81 | 4.85 | 4.70 | 4.79 | 759,977 |
| 06/05/26 | 4.59 | 4.895 | 4.4085 | 4.80 | 1,288,496 |
| 05/05/26 | 4.39 | 4.60 | 4.315 | 4.56 | 855,446 |
| 04/05/26 | 4.38 | 4.5292 | 4.33 | 4.39 | 736,457 |
| 01/05/26 | 4.39 | 4.40 | 4.22 | 4.38 | 466,300 |
| 30/04/26 | 4.19 | 4.41 | 4.175 | 4.39 | 1,505,494 |
| 29/04/26 | 4.25 | 4.26 | 4.102 | 4.15 | 387,564 |
| 28/04/26 | 3.99 | 4.35 | 3.975 | 4.27 | 1,307,063 |
| 27/04/26 | 4.08 | 4.22 | 3.93 | 3.96 | 834,224 |
|
|
||||
|
|
||||
|
|